Arcutis Biotherapeutics, Inc.
ARQT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001787306
In the last 90 days, Arcutis Biotherapeutics, Inc. insiders filed 0 open-market purchases and 12 sales; 272 institutions reported holding it in 13F filings for Q2 2026, worth $3.45B in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Arcutis Biotherapeutics, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 230
- −10 vs. Q1 2025
- Shares held
- 127.1M
- +1.39M (+1.1%) vs. Q1 2025
- Total value
- $1.78B
- −$183.9M (−9.4%) vs. Q1 2025
- New holders
- 35
- 89 more added
- Sold out
- 45
- 66 more reduced
1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARQT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 272 | $3.45B |
| Q1 2026 | 270 | $3.12B |
| Q4 2025 | 283 | $3.75B |
| Q3 2025 | 239 | $2.37B |
| Q2 2025 | 230 | $1.78B |
| Q1 2025 | 241 | $1.97B |
| Q4 2024 | 208 | $1.79B |
| Q3 2024 | 188 | $1.20B |
| Q2 2024 | 186 | $1.18B |
| Q1 2024 | 168 | $1.24B |
| Q4 2023 | 133 | $327.1M |
| Q3 2023 | 134 | $356.7M |
| Q2 2023 | 136 | $684.0M |
| Q1 2023 | 144 | $787.6M |
| Q4 2022 | 141 | $979.6M |
| Q3 2022 | 139 | $1.13B |
| Q2 2022 | 115 | $1.05B |
| Q1 2022 | 106 | $929.8M |
| Q4 2021 | 93 | $961.8M |
| Q3 2021 | 103 | $1.09B |
| Q2 2021 | 102 | $1.24B |
| Q1 2021 | 94 | $1.35B |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Arcutis Biotherapeutics, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| J. Goldman & Co LP | 860,260 | $12.1M | 0.38% | +679,739+376.5% | Added |
| Tejara Capital Ltd | 873,381 | $12.2M | 5.68% | +27,160+3.2% | Added |
| Millennium Management LLC | 910,841 | $12.8M | 0.01% | +437,216+92.3% | Added |
| PFM Health Sciences, LP | 923,375 | $12.9M | 1.12% | +923,375 | New |
| Northern Trust Corp | 928,688 | $13.0M | 0.00% | −47,382−4.9% | Reduced |
| Charles Schwab Investment Management Inc | 965,066 | $13.5M | 0.00% | +104,298+12.1% | Added |
| Cormorant Asset Management, LP | 1,000,000 | $14.0M | 1.04% | −350,000−25.9% | Reduced |
| Driehaus Capital Management LLC | 1,085,954 | $15.2M | 0.12% | −6,781−0.6% | Reduced |
| Bank of America Corp | 1,202,513 | $16.9M | 0.00% | +687,562+133.5% | Added |
| GW&K Investment Management, LLC | 1,378,432 | $19.3M | 0.17% | −133,779−8.8% | Reduced |
| Point72 Asset Management, L.P. | 1,485,425 | $20.8M | 0.05% | +654,947+78.9% | Added |
| American Century Companies Inc | 1,724,307 | $24.2M | 0.01% | +71,815+4.3% | Added |
| Goldman Sachs Group Inc | 1,890,246 | $26.5M | 0.00% | +786,833+71.3% | Added |
| Ensign Peak Advisors, Inc | 2,001,439 | $28.1M | 0.05% | +13,050+0.7% | Added |
| Pivotal bioVenture Partners Investment Advisor LLC | 2,120,508 | $29.7M | 18.43% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 2,163,001 | $30.3M | 0.03% | +173,493+8.7% | Added |
| Janus Henderson Group PLC | 2,263,960 | $31.8M | 0.02% | +2,211,360+4,204.1% | Added |
| Geode Capital Management, LLC | 2,582,567 | $36.2M | 0.00% | +35,620+1.4% | Added |
| Franklin Resources Inc | 2,732,777 | $38.3M | 0.01% | −28,990−1.0% | Reduced |
| UBS Group AG | 2,937,939 | $41.2M | 0.01% | +17,931+0.6% | Added |
| Gilder Gagnon Howe & Co LLC | 4,155,763 | $58.3M | 0.62% | +59,712+1.5% | Added |
| Morgan Stanley | 4,314,530 | $60.5M | 0.00% | +475,989+12.4% | Added |
| State Street Corp | 4,526,937 | $63.5M | 0.00% | +52,734+1.2% | Added |
| Polar Capital Holdings Plc | 5,006,475 | $70.2M | 0.37% | −1,700,000−25.3% | Reduced |
| Vanguard Group Inc | 7,049,099 | $98.8M | 0.00% | +231,021+3.4% | Added |
| BlackRock, Inc. | 8,532,761 | $119.6M | 0.00% | −359,576−4.0% | Reduced |
| Frazier Life Sciences Management, L.P. | 9,874,511 | $138.4M | 5.54% | +1,089,227+12.4% | Added |
| Rubric Capital Management LP | 10,749,457 | $150.7M | 2.42% | −217,215−2.0% | Reduced |
| Jennison Associates LLC | 11,109,405 | $155.8M | 0.09% | −251,470−2.2% | Reduced |
| Suvretta Capital Management, LLC | 11,535,582 | $161.7M | 6.09% | +112,604+1.0% | Added |
| Paradigm Biocapital Advisors LP | 0 | $0 | 0.00% | −1,465,334−100.0% | Sold out |
| Cercano Management LLC | 0 | $0 | 0.00% | −928,701−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −427,433−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −242,457−100.0% | Sold out |
| EAM Investors, LLC | 0 | $0 | 0.00% | −215,763−100.0% | Sold out |
| Twinbeech Capital LP | 0 | $0 | 0.00% | −167,764−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −118,521−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −103,373−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −86,925−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −77,035−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −68,261−100.0% | Sold out |
| Thoroughbred Financial Services, LLC | 0 | $0 | 0.00% | −59,940−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −57,908−100.0% | Sold out |
| Cookson Peirce & Co Inc | 0 | $0 | 0.00% | −57,613−100.0% | Sold out |
| Scientech Research LLC | 0 | $0 | 0.00% | −55,205−100.0% | Sold out |
| Corebridge Financial, Inc. | 0 | $0 | 0.00% | −52,662−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −36,313−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −32,566−100.0% | Sold out |
| Capula Management Ltd | 0 | $0 | 0.00% | −24,378−100.0% | Sold out |
| Blackstone Group Inc. | 0 | $0 | 0.00% | −24,144−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −21,799−100.0% | Sold out |
| Entropy Technologies, LP | 0 | $0 | 0.00% | −15,744−100.0% | Sold out |
| Pathstone Holdings, LLC | 0 | $0 | 0.00% | −15,523−100.0% | Sold out |
| Massar Capital Management, LP | 0 | $0 | 0.00% | −14,000−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −13,201−100.0% | Sold out |
| TownSquare Capital, LLC | 0 | $0 | 0.00% | −12,194−100.0% | Sold out |
| Sherbrooke Park Advisers LLC | 0 | $0 | 0.00% | −11,049−100.0% | Sold out |
| Quadrature Capital Ltd | 0 | $0 | 0.00% | −11,026−100.0% | Sold out |
| Baader Bank INC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Allostery Investments LP | 0 | $0 | 0.00% | −7,500−100.0% | Sold out |
| Nkcfo LLC | 0 | $0 | 0.00% | −7,000−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −3,280−100.0% | Sold out |
| Coldstream Capital Management Inc | 0 | $0 | 0.00% | −2,169−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −2,149−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −1,550−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −1,032−100.0% | Sold out |
| AdvisorNet Financial, Inc | 0 | $0 | 0.00% | −577−100.0% | Sold out |
| Boston Private Wealth LLC | 0 | $0 | 0.00% | −262−100.0% | Sold out |
| Aster Capital Management (DIFC) Ltd | 0 | $0 | 0.00% | −235−100.0% | Sold out |
| Mather Group, LLC. | 0 | $0 | 0.00% | −190−100.0% | Sold out |
| Amundi | 0 | $0 | 0.00% | −66−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −38−100.0% | Sold out |
| Stephens Consulting, LLC | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| True Wealth Design, LLC | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Lindbrook Capital, LLC | – | – | – | – | Not filed |